Vicken Karageozian

Company: Allegro Ophthalmics

Job title: Chief Executive Officer

Seminars:

Explore Oxidative Stress Regulating Therapy with Risuteganib in Dry-AMD 4:15 pm

A Look a pre-clinical studies with risuteganib, a synthetic RGD-class oligopeptide oxidative stress regulator, suggested to protect human RPE cells against oxidative stress-associated cellular dysfunction Learn how collectively, preclinical studies have indicated the retinal cytoprotective, anti-inflammatory, mitochondrial stabilization and antiangiogenic properties of risuteganib in in vitro and in vivo models Examine how in a Phase…Read more

day: Day One